195 related articles for article (PubMed ID: 6697321)
1. Experimental antitumor activity of 5'-nor-anhydrovinblastine navelbine.
Maral R; Bourut C; Chenu E; Mathé G
Cancer Lett; 1984 Feb; 22(1):49-54. PubMed ID: 6697321
[TBL] [Abstract][Full Text] [Related]
2. Vinca-23-oyl amino acid derivatives: as new anticancer agents (review).
Bhushana Rao KS; Collard MP; Trouet A
Anticancer Res; 1985; 5(4):379-86. PubMed ID: 3898995
[TBL] [Abstract][Full Text] [Related]
3. [Antitumor activity of navelbine (vinorelbine ditartrate), a new vinca alkaloid analog].
Ashizawa T; Miyoshi K; Asada M; Kobayashi E; Okabe M; Morimoto M; Gomi K; Hirata T
Gan To Kagaku Ryoho; 1993 Jan; 20(1):59-66. PubMed ID: 8422187
[TBL] [Abstract][Full Text] [Related]
4. Experimental in vivo cross-resistance of vinca alkaloid drugs.
Maral R; Bourut C; Chenu E; Mathe G
Cancer Chemother Pharmacol; 1981; 5(3):197-9. PubMed ID: 7296754
[TBL] [Abstract][Full Text] [Related]
5. Combination effect of navelbine (vinorelbine ditartrate) with cisplatin against murine P388 leukemia and human lung carcinoma xenografts in mice.
Ashizawa T; Asada M; Kobayashi E; Okabe M; Gomi K; Hirata T
Anticancer Drugs; 1993 Oct; 4(5):577-83. PubMed ID: 8292816
[TBL] [Abstract][Full Text] [Related]
6. Vindesine: a new vinca alkaloid.
Bayssas M; Gouveia J; de Vassal F; Misset JL; Schwarzenberg L; Ribaud P; Musset M; Jasmin C; Hayat M; Mathé G
Recent Results Cancer Res; 1980; 74():91-7. PubMed ID: 7003662
[TBL] [Abstract][Full Text] [Related]
7. Vinflunine, the latest Vinca alkaloid in clinical development. A review of its preclinical anticancer properties.
Kruczynski A; Hill BT
Crit Rev Oncol Hematol; 2001 Nov; 40(2):159-73. PubMed ID: 11682323
[TBL] [Abstract][Full Text] [Related]
8. Kinetic analysis in living cells of the inhibition of the P-glycoprotein-mediated efflux of anthracyclines by vinca alkaloids.
Pereira E; Tarasiuk J; Garnier-Suillerot A
Chem Biol Interact; 1998 Jul; 114(1-2):61-76. PubMed ID: 9744556
[TBL] [Abstract][Full Text] [Related]
9. A study of the cross-resistance of vincristine and vindesine in reinduction therapy for acute lymphocytic leukemia in relapse. A report for Children's Cancer Study Group.
Krivit W; Anderson J; Chilcote R; Pyesmany A; Chard R; Hammond D
Am J Pediatr Hematol Oncol; 1980; 2(3):217-21. PubMed ID: 7001942
[TBL] [Abstract][Full Text] [Related]
10. Comparative pharmacokinetics of antitumor Vinca alkaloids: intravenous bolus injections of navelbine and related alkaloids to cancer patients and rats.
Rahmani R; Guéritte F; Martin M; Just S; Cano JP; Barbet J
Cancer Chemother Pharmacol; 1986; 16(3):223-8. PubMed ID: 3698163
[TBL] [Abstract][Full Text] [Related]
11. Advances in vinca-alkaloids: Navelbine.
Marty M; Extra JM; Espie M; Leandri S; Besenval M; Krikorian A
Nouv Rev Fr Hematol (1978); 1989; 31(2):77-84. PubMed ID: 2671933
[TBL] [Abstract][Full Text] [Related]
12. Vinorelbine (Navelbine). A new semisynthetic vinca alkaloid.
Krikorian A; Breillout F
Onkologie; 1991 Feb; 14(1):7-12. PubMed ID: 2057177
[TBL] [Abstract][Full Text] [Related]
13. Summary of data from in vitro and phase I vinorelbine (Navelbine) studies.
Burris HA; Fields S
Semin Oncol; 1994 Oct; 21(5 Suppl 10):14-9; discussion 19-20. PubMed ID: 7973764
[TBL] [Abstract][Full Text] [Related]
14. Vinblastin-23-oyl amino acid derivatives: chemistry, physicochemical data, toxicity, and antitumor activities against P388 and L1210 leukemias.
Bhushana Rao KS; Collard MP; Dejonghe JP; Atassi G; Hannart JA; Trouet A
J Med Chem; 1985 Aug; 28(8):1079-88. PubMed ID: 4020828
[TBL] [Abstract][Full Text] [Related]
15. Preclinical in vivo antitumor activity of vinflunine, a novel fluorinated Vinca alkaloid.
Kruczynski A; Colpaert F; Tarayre JP; Mouillard P; Fahy J; Hill BT
Cancer Chemother Pharmacol; 1998; 41(6):437-47. PubMed ID: 9554586
[TBL] [Abstract][Full Text] [Related]
16. The effect of vinca alkaloids in enhancing the sensitivity of a methotrexate-resistant (L1210/R7A) line, studied by flow cytometric and chromosome number analysis.
McGown AT; Poppitt DG; Swindell R; Fox BW
Cancer Chemother Pharmacol; 1984; 13(1):47-53. PubMed ID: 6733842
[TBL] [Abstract][Full Text] [Related]
17. Collateral sensitivity of a methotrexate-resistant L1210 cell line to the vinca alkaloids.
Poppitt DG; McGown AT; Fox BW
Cancer Chemother Pharmacol; 1984; 13(1):43-6. PubMed ID: 6733841
[TBL] [Abstract][Full Text] [Related]
18. Identification of Vinca alkaloid acceptors in P388 murine leukemia cells with a photoactive analogue of vinblastine.
Safa AR; Glover CJ; Felsted RL
Cancer Res; 1987 Oct; 47(19):5149-54. PubMed ID: 3621200
[TBL] [Abstract][Full Text] [Related]
19. Induced resistance in leukaemia L1210 to adriamycin and its cross-resistance to vincristine and bouvardin.
Chitnis MP; Joshi SS; Gude RP; Menon RS
Chemotherapy; 1982; 28(3):209-12. PubMed ID: 7094661
[TBL] [Abstract][Full Text] [Related]
20. Current NCI preclinical antitumor screening in vivo: results of tumor panel screening, 1976-1982, and future directions.
Venditti JM; Wesley RA; Plowman J
Adv Pharmacol Chemother; 1984; 20():1-20. PubMed ID: 6398966
[No Abstract] [Full Text] [Related]
[Next] [New Search]
